Elsevier

Experimental Eye Research

Volume 91, Issue 3, September 2010, Pages 425-432
Experimental Eye Research

Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo

https://doi.org/10.1016/j.exer.2010.06.017Get rights and content

Abstract

The P2X7 receptor is associated with the death of many cell types, and growing evidence supports its presence on neurons. Activation of the P2X7 receptor on isolated retinal ganglion cells increases intracellular calcium levels and can kill the cells. Within the intact eye, however, glia and other cell types surrounding the ganglion cells may provide protection and attenuate the effects of receptor stimulation. This investigation thus asks whether stimulation of the P2X7 receptor can actually kill retinal ganglion cells in vivo. Drugs were injected intravitreally into the superior/nasal region of Long Evans rats. Cell survival was determined by counting the number of remaining ganglion cells labeled with aminostilbamidine. The P2X7 receptor agonist BzATP reduced ganglion cell survival as compared to eyes injected with saline solution. Ganglion cell death was inhibited by co-injection of the P2X7 antagonists Brilliant Blue G and MRS 2540. The loss of ganglion cells following activation of the P2X7 receptor was also prevented by the adenosine A3 adenosine receptor agonist MRS 3558. In conclusion, stimulation of the P2X7 receptor can kill retinal ganglion cells in vivo. The neuroprotective effects of A3 receptor activation identified in isolated ganglion cells are also apparent in vivo. This implies that the balance between extracellular ATP and its protective metabolite adenosine can influence ganglion cell survival in the living eye.

Research Highlights: ►Stimulation of P2X7 receptor for ATP kills retinal ganglion cells in vivo, ►Block of P2X7 receptor with antagonists BBG or MRS 2540 protects neurons, ►Stimulation of A3 adenosine receptor neuroprotective, ►Suggests balance of purines alters ganglion cell fate in vivo like in vitro

Introduction

The purines ATP and adenosine act as transmitters throughout the nervous system, with ATP stimulating metabotropic P2Y and ionotropic P2X receptors, while adenosine acts at metabotropic A1, A2A, A2B or A3 receptors (Ribeiro et al., 2002, Abbracchio et al., 2009). The dephosphorylation of ATP into adenosine by extracellular enzymes can consequently influence signaling (Zimmermann, 2000, Zuo et al., 2008), and retinal ganglion cells highlight a particularly extreme example of these interactions. Previous work has demonstrated that stimulation of the P2X7 receptor killed isolated retinal ganglion cells in vitro (Zhang et al., 2005) while stimulation of the A3 adenosine receptor enhanced their survival (Zhang et al., 2006b). In these isolated ganglion cells, the lethal action of P2X7 receptor stimulation corresponded with elevations in cytoplasmic Ca2+, while A3 receptor activation reduced the Ca2+ response.

While these in vitro experiments clearly demonstrated the lethal potential of P2X7 receptors and the contrasting neuroprotective potential of adenosine A3 receptors on isolated ganglion cells, it is not currently known whether these findings can be reproduced in an intact animal. The mechanical and chemical dissociation of neuronal cells leaves them considerably more fragile than they are in their native environment. Even the removal of the inner limiting membrane may decrease ganglion cell survival (Halfter et al., 2005). Moreover, retinal ganglion cell somata lie close to Müller and astrocytic glial cells in addition to other cells that can release protective compounds (Newman, 2003, Bringmann et al., 2009). It is thus possible that ganglion cells may be more resistant to stress in vivo than in vitro.

This study asked whether stimulation of the P2X7 receptor kills retinal ganglion cells in vivo as it does in vitro. In addition, the ability of the A3 adenosine receptor to prevent ganglion cell death in vivo was examined. We demonstrate that in vitro findings are relevant to the intact retina, and that the balance of extracellular purines can alter ganglion cell health in vivo.

Section snippets

Materials

MRS 3558 (1′S,2′R,3′S,4′R,5′S)-4-(2-chloro-6-(3-chlorobenzylamino)-9H-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide and MRS 2540 ((S)-4-(3-(4-benzoylpiperazin-1-yl)-2-(benzyloxycarbonylamino)-3-oxopropyl)-3,5-dimethylphenyl 4-methylbenzenesulfonate) were developed at theLaboratory of Bioorganic Chemistry NIDDK, National Institutes of Health (Jacobson et al., 2005, Tchilibon et al., 2005). All other materials are from Sigma Chemical Corp (St. Louis, MO), unless otherwise

Ganglion cell distribution in control retinas

Initial experiments were performed to determine the number of ganglion cells in control eyes of adolescent rats PD14 to 26. Sterile saline was injected into the region between the nasal and superior quadrants, and 2–3 days later the fluorescent label aminostilbamidine was injected into the superior colliculus. After allowing several days for retrograde transport of the dye along axons into the ganglion cell soma, the retina was removed and inspected. Fluorescent ganglion cells were clearly

Discussion

This study has demonstrated that in vivo injection of the P2X7 receptor agonist BzATP into the vitreal chamber reduces ganglion cell number, and that cell loss could be prevented by P2X7 receptor antagonists. In addition, ganglion cell loss was prevented by co-stimulation of an A3 adenosine receptor. On this basis, we conclude that the neurochemical pathways elucidated on isolated ganglion cells in vitro also function in vivo. In particular, these findings suggest that the balance between

Acknowledgements

This work is supported by grants from the NIH EY015537 and EY013434 (CHM), Vision Research Core Grant EY001583 (CHM and AML), Research to Prevent Blindness (AML), the Paul and Evanina Bell Mackall Foundation Trust (AML), the Jody Sack Fund (HH, MZ and XZ), the National Natural Science Foundation of China 30872831(XZ), by support from the Intramural Research Program of NIDDK, NIH, Bethesda, MD (KAJ), and by Basic Science Research Program through the National Research Foundation of Korea (NRF)

References (36)

  • P. Zuo et al.

    Mathematical model of nucleotide regulation on airway epithelia: IImplications for airway homeostasis

    J. Biol. Chem.

    (2008)
  • X. Bo et al.

    Pharmacological and biophysical properties of the human P2X5 receptor

    Mol. Pharmacol.

    (2003)
  • L.M.G. Carrasquero et al.

    Miras-Portugal MT P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes

    J. Neurochem.

    (2009)
  • D. Communi et al.

    Pharmacological characterization of the human P2Y11 receptor

    Br. J. Pharmacol.

    (1999)
  • H. Enaida et al.

    Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G

    Retina

    (2006)
  • L. Guo et al.

    Retinal ganglion cell apoptosis in glaucoma Is related to intraocular pressure and IOP-induced effects on extracellular matrix

    Invest. Ophthalmol. Vis. Sci.

    (2005)
  • W. Halfter et al.

    Basement membrane-dependent survival of retinal ganglion cells

    Invest. Ophthalmol. Vis. Sci.

    (2005)
  • H. Hu et al.

    Mitchell CH Stimulation of P2X7 receptor kills rat retinal ganglion cells in vivo

    Invest. Ophthalmol. Vis. Sci.

    (2008)
  • Cited by (0)

    View full text